| Exam Code/Number: | BPS-PharmacotherapyJoin the discussion |
| Exam Name: | Pharmacotherapy (Part1 and Part2) Exam |
| Certification: | BPS |
| Question Number: | 175 |
| Publish Date: | Jun 03, 2026 |
|
Rating
100%
|
|
Which of the following is a risk factor for the development of multidrug resistance in pathogens that cause nosocomial pneumonia?
A 47-year-old patient with type 2 diabetes mellitus and no known coronary heart disease has the following fasting lipid profile. HDL cholesterol = 40 mg/dL, LDL cholesterol = 164 mg/dL, and triglycerides = 150 mg/dL. The patient has an ASCVD 10-year risk score of 6%. According to the ACC/AHA, which of the following is the most appropriate intervention for this patient's LDL?
A 66-year-old man with a history of chronic bronchitis is seen in October for treatment of an acute exacerbation. He received the pneumococcal vaccine 3 years ago and an influenza vaccine this past March. Which of the following should the pharmacotherapy specialist recommend?
An 18-year-old patient presents with abrasions on the hands, knees, and shoulder from a recent bicycle accident. Gram-staining of surgical incision and drainage specimens reveals Gram positive cocci in chains. The patient has necrotizing fasciitis and develops bronchospasms after being given penicillin. Which intravenous antibiotic would be best to use in place of penicillin?
Investigators studying the relative nephrotoxicity of two aminoglycosides selected their sample size to detect a reduction in toxicity of 10%. Which of the following is the power of this study if the probability of falsely rejecting the null hypothesis is 0.05 and the probability of falsely accepting the null hypothesis is 0.20?
